Nashville, TN 37201
Schedule: November 11, 2010
10 a.m. Life Science Legal and Regulatory Update (CLE CREDIT) - Ryman Room
A look at the key legal and regulatory issues facing life sciences companies. More than ever, these issues are impacting the ability of new ventures to raise outside capital. Learn why many VCs are choosing not to invest in companies that haven’t already gained the necessary FDA approvals and what you can do about it.
Mike Druckman, Hogan Lovells
Nicholas Landau, Bradley Arant Boult Cummings